Freedom® Portable Driver Surpasses 1,200 Days of Patient Life Powering SynCardia's Total Artificial Heart
French Total Artificial Heart Patients Enjoy Life at Home While Waiting for a Donor Heart
® driver, the world's first wearable portable driver for powering the SynCardia temporary Total Artificial Heart both inside and outside the hospital, now accounts for more than 1,200 days of patient life.TUCSON, Ariz. – Dec. 9, 2010 – SynCardia Systems, Inc. announced today that the Freedom
A total of 19 patients in the U.S., Europe and Australia have been supported by the Freedom driver. Groupe Hospitalier La Pitié-Salpêtrière in Paris, which leads all SynCardia Certified Centers worldwide in number of implants at 206, currently has two Total Artificial Heart patients discharged home while they wait for a matching donor heart.
Christian Lediouron: This 31-year-old husband and father of two was admitted to the hospital on May 8, 2010, suffering from dilated cardiomyopathy with an ejection fraction of only 10%. On May 17, doctors implanted the Total Artificial Heart as a lifesaving bridge to transplant until a donor heart becomes available. Approximately 5 weeks after the implant surgery, Mr. Lediouron's condition had stabilized and he was discharged from the hospital using the Freedom driver. Since returning home to his wife of 7 years, Karene, and their two young daughters, Sidney and Wendy, Mr. Lediouron says, "There is nothing better. I can work at home; play with my children; live like other normal people without difficulty."
Antonio Amoussou: This 40-year-old business manager originally from Parakou, Benin, West Africa, was admitted to the hospital on Feb. 12, 2010, suffering from dilated cardiomyopathy. Just four days later, doctors implanted the Total Artificial Heart to save Mr. Amoussou's life until a matching donor heart becomes available. Since being discharged home with the Freedom driver, Mr. Amoussou says he has been exercising for up to 45 minutes at a time - walking as far as 3 km on the treadmill - as well as eating out at restaurants, going on long walks and doing laundry.
The Freedom driver has been CE approved for commercial use in Europe and is currently undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463